EMA: Draft GL for OIPs [BE/BA News]

posted by Ohlbe – France, 2024-04-22 16:07 (28 d 13:05 ago) – Posting: # 23961
Views: 866

Dear Chirag,

❝ Since this is my first post, I apologize for any errors.


No error, and welcome to the forum.

❝ Upon reading, I noticed that the recently introduced guidelines still relate to Directive 2001/20/EC rather than 536/2014.


You're absolutely right, the guideline should refer to the Clinical Trial Regulation and no longer to the Clinical Trial Directive. There was a first public consultation to revise this guideline in 2017 (before the CTR came into force), and it looks like they failed to update this paragraph after that.

The document just published is again a draft for public consultation. Hopefully this will be pointed out and corrected.

Regards
Ohlbe

Complete thread:

UA Flag
Activity
 Admin contact
23,033 posts in 4,835 threads, 1,647 registered users;
46 visitors (0 registered, 46 guests [including 7 identified bots]).
Forum time: 05:12 CEST (Europe/Vienna)

Give me a fruitful error any time, full of seeds, bursting with its own corrections.
You can keep your sterile truth for yourself.    Vilfredo Pareto

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5